Clinical Trials
13 trialsNCT03084536 2024-12-24
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
Washington University School of Medicine
Phase 2 Completed
NCT06017141 2023-08-30
Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study
University of Kansas Medical Center
Phase 2 Unknown
NCT04635852 2020-11-19
EFFENDYS
University of Cologne
Phase 2 Completed
NCT03809455 2020-04-22
FARADI
UNICANCER
Phase 2 Withdrawn
NCT03071744 2019-12-09
Lazanda in Cancer Patients Receiving Palliative Radiation
University of California, San Diego
Phase 2 Terminated
NCT01516684 2019-09-06
Local Anesthetic Cream in Younger Patients Undergoing Lumbar Punctures
Wake Forest University Health Sciences
Phase 2 Completed
NCT01703351 2019-01-31
Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy
Yonsei University
Phase 2 Completed
NCT02861716 2018-04-10
Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery
South Egypt Cancer Institute
Phase 2 Unknown
NCT00236041 2014-05-09
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT00236093 2014-05-09
Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT00355628 2012-08-31
Clinical Study of KW-2246 in Patients With Cancer Pain
Kyowa Kirin Co., Ltd.
Phase 2 Completed
NCT00345735 2012-05-07
Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)
Nycomed
Phase 2 Completed
NCT00216658 2011-01-24
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
Janssen Pharmaceutical K.K.
Phase 2 Completed